Are phosphodiesterase Type 5 inhibitors potential therapies for Alzheimer’s disease and related dementias?

This scientific commentary refers to ‘No association between initiation of phosphodiesterase-5 inhibitors and risk of incident Alzheimer’s disease and related dementia: results from the Drug Repurposing for Effective Alzheimer’s Medicines (DREAM) study’ by Desai et al. (https://doi.org/10.1093/brain...

Descripción completa

Detalles Bibliográficos
Autor principal: Newby, Danielle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Scientific Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9598549/
https://www.ncbi.nlm.nih.gov/pubmed/36324868
http://dx.doi.org/10.1093/braincomms/fcac260

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9598549/
https://www.ncbi.nlm.nih.gov/pubmed/36324868
http://dx.doi.org/10.1093/braincomms/fcac260

Ejemplares similares